Breast cancer: Role of neoadjuvant therapy

被引：16

作者：

Ahmed, Muhammad Ishtiaq ^{[1
]}

Lennard, T. W. J. ^{[1
]}

机构：

[1] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England

来源：

INTERNATIONAL JOURNAL OF SURGERY | 2009年 / 7卷 / 05期

关键词：

Breast cancer; Neoadjuvant; Adjuvant; Chemotherapy; Endocrine; Axilla; SURGICAL ADJUVANT BREAST; SENTINEL NODE BIOPSY; PREOPERATIVE CHEMOTHERAPY; SYSTEMIC TREATMENT; TAMOXIFEN; WOMEN; CYCLOPHOSPHAMIDE; ANASTROZOLE; COMBINATION; LETROZOLE;

D O I：

10.1016/j.ijsu.2009.06.001

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Breast cancer is now considered to be a systemic disease from the outset, with no correlation seen between the intensity of local treatment and survival or recurrence. Adjuvant therapy has clearly demonstrated a reduction in local and distant relapse; neoadjuvant therapy is similarly being assessed. It aims to treat occult metastases and decrease tumour bulk. Its use has demonstrated down-staging of the tumour with increased rates of breast-conserving surgery. Though neoadjuvant therapy seems to be associated with an increase in loco-regional recurrence compared to adjuvant therapy, no overall difference in survival has been demonstrated. This paper reviews several trials that compare neoadjuvant to adjuvant therapy, and the controversies around managing the axilla in the neoadjuvant setting. (C) 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

引用

页码：416 / 420

页数：5

共 31 条

[1] Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27 [J].

Bear, HD ;

Anderson, S ;

Smith, RE ;

Geyer, CE ;

Mamounas, EP ;

Fisher, B ;

Brown, AM ;

Robidoux, A ;

Margolese, R ;

Kahlenberg, MS ;

Paik, S ;

Soran, A ;

Wickerham, DL ;

Wolmark, N .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :2019-2027

[2] COMBINATION CHEMOTHERAPY AS AN ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER [J].

BONADONNA, G ;

BRUSAMOLINO, E ;

VALAGUSSA, P ;

ROSSI, A ;

BRUGNATELLI, L ;

BRAMBILLA, C ;

DELENA, M ;

TANCINI, G ;

BAJETTA, E ;

MUSUMECI, R ;

VERONESI, U .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (08) :405-410

[3] Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: Results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer [J].

Buzdar, AU ;

Ibrahim, NK ;

Francis, D ;

Booser, DJ ;

Thomas, ES ;

Theriault, RL ;

Pusztai, L ;

Green, MC ;

Arun, BK ;

Giordano, SH ;

Cristofanilli, M ;

Frye, DK ;

Smith, TL ;

Hunt, KK ;

Singletary, SE ;

Sahin, AA ;

Ewer, MS ;

Buchholz, TA ;

Berry, D ;

Hortobagyi, GN .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3676-3685

[4]

BUZDAR AU, 2003, 26 ANN SAN ANT BREAS

[5] Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer - The Pre-Operative "Arimidex" Compared to Tamoxilen (PROAC7) trial [J].

Cataliotti, L ;

Buzdar, AU ;

Noguchi, S ;

Bines, J ;

Takatsuka, Y ;

Petrakova, K ;

Dube, P ;

de Oliveira, CT .

CANCER, 2006, 106 (10) :2095-2103

[6] Neoadjuvant chemotherapy in breast cancer [J].

Charfare, H ;

Limongelli, S ;

Purushotham, AD .

BRITISH JOURNAL OF SURGERY, 2005, 92 (01) :14-23

[7] THE NATIONAL-CANCER-INSTITUTE AUDIT OF THE NATIONAL-SURGICAL-ADJUVANT-BREAST-AND-BOWEL-PROJECT-PROTOCOL-B-06 [J].

CHRISTIAN, MC ;

MCCABE, MS ;

KORN, EL ;

ABRAMS, JS ;

KAPLAN, RS ;

FRIEDMAN, MA .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (22) :1469-1474

[8] Letrozole as primary medical therapy for locally advanced and large operable breast cancer [J].

Dixon, JM ;

Love, CDB ;

Bellamy, COC ;

Cameron, DA ;

Leonard, RCF ;

Smith, H ;

Miller, WR .

BREAST CANCER RESEARCH AND TREATMENT, 2001, 66 (03) :191-199

[9] Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study [J].

Eiermann, W ;

Paepke, S ;

Appfelstaedt, J ;

Llombart-Cussac, A ;

Eremin, J ;

Vinholes, J ;

Mauriac, L ;

Ellis, M ;

Lassus, M ;

Chaudri-Ross, HA ;

Dugan, M ;

Borgs, M ;

Semiglazov, V .

ANNALS OF ONCOLOGY, 2001, 12 (11) :1527-1532

[10] Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy [J].

Fentiman, IS ;

Christiaens, MR ;

Paridaens, R ;

Van Geel, A ;

Rutgers, E ;

Berner, J ;

de Keizer, G ;

Wildiers, J ;

Nagadowska, M ;

Legrand, C ;

Therasse, P .

EUROPEAN JOURNAL OF CANCER, 2003, 39 (03) :309-316

← 1 2 3 4 →